Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $177.8 million versus the consensus estimate of $167.5 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2025 EPS of $0.85-$0.95, versus the consensus of $0.80. Avanos Medical, Inc. sees FY2025 revenue of $690-700 million, versus the consensus of $676 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.